Found: 5
Select item for more details and to access through your institution.
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries.
- Published in:
- Rheumatology, 2012, v. 51, n. 2, p. 393, doi. 10.1093/rheumatology/ker404
- By:
- Publication type:
- Article
Treatment strategies in patients with major depression not responding to first-line sertraline treatment: A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
- Published in:
- Psychopharmacology, 2002, v. 161, n. 2, p. 143, doi. 10.1007/s00213-002-0999-0
- By:
- Publication type:
- Article
A Higher Score on the Dermatology Life Quality Index, Being on Systemic Treatment and Having a Diagnosis of Psoriatic Arthritis is Associated with Increased Costs in Patients with Plaque Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2013, v. 93, n. 6, p. 684, doi. 10.2340/00015555-1591
- By:
- Publication type:
- Article
The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy.
- Published in:
- Acta Dermato-Venereologica, 2008, v. 88, n. 5, p. 495, doi. 10.2340/00015555-0511
- By:
- Publication type:
- Article